Entering text into the input field will update the search result below
Join now
Search for Symbols, analysts, keywords
Log in
News
Show Full Stories
Ionis, AbbVie, Alnylam draw bullish views at Raymond James
Drug developer Adlai Nortye sees stock sink 27% in market debut
Ginkgo Bioworks stock gains on USDA grant to study SARS-CoV-2
Carlyle in talks for $7B-plus Medtronic units deal - Reuters
Regeneron nabs FDA priority review for lymphoma therapy
Hepion to sell $5M in shares through registered direct offering
Walgreens reportedly eyeing ex-Cigna executive for CEO role
Lexaria Bioscience enters into securities purchase agreement
Psychedelic drugs market to break $7B in 2029 led by these 3 meds
Curis, Corcept Therapeutics among healthcare movers
Corcept Therapeutics plunges amid patent trial with Teva
Adlai Nortye raises $98M through IPO, private placement
Capricor says FDA aligns with path to market lead asset
Renovaro Biosciences to combine with GEDi Cube
Filament Health to raise up to C$2M in non-brokered private placement
Capricor Therapeutics slumps 25%, prices $23M equity
Structure Therapeutics surges after early-stage data for oral weight loss agent
Portage Biotech stock sheds after announcing $6M registered direct offering
Lexaria Bioscience enters into securities purchase agreement
Lexaria Bioscience enters into securities purchase agreement
Dentsply Sirona names Gregory Lucier board chairman
Harrow Health changes name to Harrow
AbbVie blood cancer therapy fails in Phase 3 trial
Editas gains as Stifel upgrades on sickle cell disease potential
Madrigal Pharmaceuticals prices of $500 million stock offering
1
2
3
4
5
Next
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
